-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was $23.8M.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$7.01M, a 64.1% decline from 2021.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$4.27M, a 79% decline from 2020.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$2.39M, a 21% increase from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)